Here are more fascinating facts about caffeine and cancer.

Caffeine affects the immune system via at least two opposing mechanisms.

Mechanism 1: A2A receptor antagonism (immunostimulatory) Tumors and damaged tissues release adenosine, which engages the A2A receptor on immune cells and signals them to stand down. Caffeine antagonizes (i.e., blocks) this receptor.

Mechanism 2: Raising intracellular cAMP (immunosuppressive) Caffeine also inhibits phosphodiesterase, the enzyme that hydrolyzes (i.e., breaks down) cAMP. cAMP accumulates inside immune cells, which acts as a "calm down" signal.

Note: both mechanisms are dose-dependent. At dietary caffeine levels, A2A antagonism likely dominates, whereas PDE inhibition is weak and mainly relevant at higher concentrations. However, the net immune effect in the tumor microenvironment remains unproven.

---

If you would like to learn more, I can outline a framework for technical folks to ease in and become more informed on cancer. Gaps abound. The more people who understand cancer, the faster we get to cures. Moreover, personalized cancer treatment is the obvious future. Knowledge acquired now may pay off later (but hopefully not needed).

On second thought, I will publish something regardless of interest.

It will be an "Cancer for Engineers" framework, delivered via free, open-source Custom GPTs and Claude Skills. (Gemini gems are less reliable in our experience.)

The goal: to ease engineers into cancer via AI personalized introductory curriculums with varying time commitments to enable deeper independent investigation or fast exits if interest wanes: 4 hours, 8 hours, 12 hours.

Basically 1-3 hours per week for a month.

The reason I think some engineers may find cancer interesting, aside from the societal impact:

The human body is like a complex operating system. Cancer is a severe runtime error. Tracing root causes -- like genetic mutations, signaling errors, or immune evasion -- has many parallels to diagnosing system failures.

BTW if anyone from Kaggle/GDM is reading this, we are having issues submitting a benchmark paper for NeurIPS based on the Kaggle Benchmark.

Google models seem to get a different scheduling priority, ironically, enough and take >20 hours to complete a benchmark task that other models like Opus 4.6 finish in <1 hour -- same code path, same task. Would love help if possible since the abstract deadline is Monday (It's last minute because we didn't originally plan to submit this, but someone suggested it.)

I'm always up for learning more about everything. Point me in the right direction?

Absolutely. I was recently diagnosed with MPN, an odd “you’re probably fine” blood cancer, looking to learn everything.